Lyme disease spirochaete Borrelia burgdorferi does not require thiamin

被引:0
|
作者
Kai Zhang
Jiang Bian
Yijie Deng
Alexis Smith
Roy E. Nunez
Michael B. Li
Utpal Pal
Ai-Ming Yu
Weigang Qiu
Steven E. Ealick
Chunhao Li
机构
[1] State University of New York at Buffalo,Department of Oral Biology
[2] University of Maryland,Department of Veterinary Medicine
[3] The City University of New York,Department of Biological Sciences
[4] UC Davis School of Medicine,Department of Biochemistry & Molecular Medicine
[5] Cornell University,Department of Chemistry and Chemical Biology
[6] State University of New York at Buffalo,Department of Microbiology and Immunology
[7] ‡ Present address: Weinberg College of Arts and Sciences,undefined
[8] Northwestern University,undefined
[9] Evanston,undefined
[10] Illinois 60208,undefined
[11] USA,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Thiamin pyrophosphate (ThDP), the active form of thiamin (vitamin B1), is believed to be an essential cofactor for all living organisms1,2. Here, we report the unprecedented result that thiamin is dispensable for the growth of the Lyme disease pathogen Borrelia burgdorferi (Bb)3. Bb lacks genes for thiamin biosynthesis and transport as well as known ThDP-dependent enzymes4, and we were unable to detect thiamin or its derivatives in Bb cells. We showed that eliminating thiamin in vitro and in vivo using BcmE, an enzyme that degrades thiamin, has no impact on Bb growth and survival during its enzootic infectious cycle. Finally, high-performance liquid chromatography analysis reveals that the level of thiamin and its derivatives in Ixodes scapularis ticks, the enzootic vector of Bb, is extremely low. These results suggest that by dispensing with use of thiamin, Borrelia, and perhaps other tick-transmitted bacterial pathogens, are uniquely adapted to survive in tick vectors before transmitting to mammalian hosts. To our knowledge, such a mechanism has not been reported previously in any living organisms.
引用
收藏
相关论文
共 50 条
  • [21] A cheA cheW operon in Borrelia burgdorferi, the agent of Lyme disease
    Trueba, GA
    Old, IG
    SaintGirons, I
    Johnson, RC
    RESEARCH IN MICROBIOLOGY, 1997, 148 (03) : 191 - 200
  • [22] Posterior scleritis associated with Borrelia burgdorferi (Lyme disease) infection
    Krist, D
    Wenkel, H
    OPHTHALMOLOGY, 2002, 109 (01) : 143 - 145
  • [23] Synthesis of autoinducer 2 by the Lyme disease spirochete, Borrelia burgdorferi
    Babb, K
    von Lackum, K
    Wattier, RL
    Riley, SP
    Stevenson, B
    JOURNAL OF BACTERIOLOGY, 2005, 187 (09) : 3079 - 3087
  • [24] Current aspects of Lyme disease and other Borrelia burgdorferi infections
    Berger, BW
    DERMATOLOGIC CLINICS, 1997, 15 (02) : 247 - +
  • [25] Survival strategies of Borrelia burgdorferi, the etiologic agent of Lyme disease
    Embers, ME
    Ramamoorthy, R
    Philipp, MT
    MICROBES AND INFECTION, 2004, 6 (03) : 312 - 318
  • [26] Transformation of the Lyme disease spirochete Borrelia burgdorferi with heterologous DNA
    Stevenson, B
    Bono, JL
    Elias, A
    Tilly, K
    Rosa, P
    JOURNAL OF BACTERIOLOGY, 1998, 180 (18) : 4850 - 4855
  • [27] Biodiversity of Borrelia burgdorferi Strains in Tissues of Lyme Disease Patients
    Brisson, Dustin
    Baxamusa, Nilofer
    Schwartz, Ira
    Wormser, Gary P.
    PLOS ONE, 2011, 6 (08):
  • [28] T cell immunity to Borrelia burgdorferi in patients with Lyme disease
    Wallich, R
    Bauer, Y
    Simon, MM
    Hofmann, H
    ZENTRALBLATT FUR BAKTERIOLOGIE-INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY VIROLOGY PARASITOLOGY AND INFECTIOUS DISEASES, 1999, 289 (5-7): : 674 - 674
  • [29] Molecular survival strategies of the Lyme disease spirochete Borrelia burgdorferi
    Singh, SK
    Girschick, HJ
    LANCET INFECTIOUS DISEASES, 2004, 4 (09): : 575 - 583
  • [30] Orbital myositis associated with Borrelia burgdorferi (Lyme disease) infection
    Carvounis, PE
    Mehta, AP
    Geist, CE
    OPHTHALMOLOGY, 2004, 111 (05) : 1023 - 1028